Pulse Biosciences, Inc Common Stock (DE)
PLSEStock
$27.38+72.93%52W
Market Cap$1.86B
P/E—
Div yield—
Beta1.59
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)63.70%
Price vs S&P 500 (4W)4.22%
VGM Score41.07
Market Capitalization$1.86B
Earnings Surprise History
Q1 26-0.24est. -0.32
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.25
4.25
4.25
4.22
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PLSEPulse Biosciences, Inc Common Stock (DE) | F | — | A | $27.38 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
Pulse Biosciences develops Nano-Pulse Stimulation (NPS), a proprietary bioelectric medicine technology that uses precise nanosecond electrical pulses to remove diseased cells while preserving surrounding healthy tissue. The platform addresses multiple medical indications where current treatment options are insufficient or suboptimal. NPS represents a potentially transformative approach for treating conditions across various therapeutic areas.